MMMaria A. Morozova

Maria A. Morozova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria A. Morozova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Detection and Quantification of Polymorphic MICA and MICB Molecules in Immunoassays: Initial Insights

    by A. Yu. Stolbovaya, A. A. Pinevich, I. V. Gryazeva, I. Yu. Krutetskaya, G. M. Zharinov, M. A. Morozova, A. Yu. Kneev, L. A. Terekhina, S. A. Ishchuk, O. A. Shashkova, et al.

    The MICA and MICB molecules, expressed on the cell membrane in response to cellular stress or cancer transformation, pose significant challenges for immunoassays. They exhibit high sequence and structural similarity, alongside considerable allelic polymorphism, with 291 and 53 known protein sequences, respectively. Some researchers treat MICA and MICB as a unified target because of their structural and functional similarities, while others distinguish between them. However, which approach is superior and under what circumstances remains unknown. Moreover, information about assays' reactivity with MICA and MICB allelic variants is often missing. In this study, we developed 10 monoclonal antibodies (mAbs) and two sandwich ELISAs for the detection and quantification of these molecules. We assembled a panel of recombinant proteins representing the diversity of MICA and MICB in the European population and profiled the reactivities of the mAbs and ELISAs. The performance of these sandwich ELISAs was evaluated using samples from prostate cancer patients and pregnant women experiencing premature rupture of membranes. Our study assessed the impact of MICA and MICB polymorphism on their detection and quantification by immunological methods, providing evidence to support differential or non‐differential approaches for their detection.


  • Biomarkers of inflammation and neoangiogenesis in premature rupture of membranes

    by Maria A. Morozova, Vitaly F. Bezhenar, Irina V. Kholopova, Alexandra V. Mazing, Tatyana V. Blinova, Ilya V. Smirnov, Olesya A. Grigoryeva, Григорьева Олеся Алексеевна

    BACKGROUND: Premature rupture of membranes complicates up to 2–10% of full-term pregnancies and up to 40% of all premature pregnancies. It is believed that the main cause of premature rupture of membranes is inflammation caused by both infectious agents and autoimmune processes. Numerous studies are aimed at searching for biomarkers that can predict inflammation in premature rupture of membranes. AIM: The aim of this study was to determine the levels of pro-inflammatory cytokines such as interleukin-6, -18 and procalcitonin, as well as interferon-α and soluble endoglin, in the blood serum of pregnant women with premature rupture of membranes and women in labor with timely discharge of amniotic fluid and evaluate the possibility of using these parameters to optimize obstetric tactics. MATERIALS AND METHODS: This study included 69 patients delivered at the Clinic of Obstetrics and Gynecology of the Academician I.P. Pavlov First Saint Petersburg State Medical University from January 2022 to March 2023. The main study group consisted of 53 pregnant women with premature rupture of membranes, the control group included 16 women with term labor and timely discharge of amniotic fluid, or amniotomy performed in the first stage of labor. The levels of interleukin-6, -18, interferon-α, procalcitonin and soluble endoglin in maternal peripheral blood were assessed using enzyme-linked immunosorbent assay. Pregnancies complicated by severe preeclampsia, placenta abruption and chronic maternal diseases in the acute stage were excluded from the study. RESULTS: At the time of rupture, the minimum gestational age was 33+0 weeks and the maximum age — 41+3 weeks. The median duration of the anhydrous interval was 31.8 hours. No significant differences in interleukin-6, -18, procalcitonin and soluble endoglin concentrations were revealed in the main and control groups, interferon-α level being higher in the comparison group. The median concentration of interferon-α in pregnant women with premature rupture of membranes was 1.64 pg/ml and in women with timely discharge of amniotic fluid — 4.61 pg/ml (p = 0.001). A weak direct correlation was revealed between soluble endoglin and interleukin-18 concentrations (R = 0.26; p = 0.03), as well as a moderate direct correlation between soluble endoglin and procalcitonin levels (R = 0.4; p 0.001). CONCLUSIONS: The study did not reveal differences in the concentrations of interleukin-6, -18, procalcitonin and soluble endoglin in the comparison groups. A decrease in interferon-α level in the blood in pregnant women increases the risk of developing premature rupture of membranes. The correlations between soluble endoglin and interleukin-18 or procalcitonin concentrations may indicate an association between different mechanisms of the pathogenesis of premature rupture of membranes. In this regard, an integrated approach and analysis of a combination of several cellular bioregulators are eligible to predict infectious complications in premature rupture of membranes.

  • Premature rupture of membranes: the current state of the problem and approaches to the rational tactics of labor management

    by Maria A. Morozova, Vitaly F. Bezhenar

    Premature rupture of membranes occurs in 220% of all pregnancies. The possibility of identifying risk factors and pre dicting this complication are of great interest in practical obstetrics. This review article highlights the current state of the problem and presents approaches to the rational tactics of labor management in case of premature rupture of membranes. We also present the algorithms for the management of labor in the Obstetrics and Gynecology Clinic, Academician I.P. Pavlov First Saint Petersburg State Medical University.

  • Giant extragastrointestinal tumor in gynecological practice

    by Bezhenar V.F. Bezhenar, Rybakova M.G. Rybakova, Arakelyan B.V. Arakelyan, Kuzmina N.S. Kuzmina N, Nutfullina G.M. Nutfullina, Medvedeva I.V. Medvedeva, Morozova M.A. Morozova